Carcamo P, Walter E, Frei C, Yang L, Cadena J, Hopkins T
BMC Infect Dis. 2025; 25(1):302.
PMID: 40033251
PMC: 11874385.
DOI: 10.1186/s12879-025-10494-5.
Ticac M, Grubic Kezele T, Bubonja Sonje M
Antibiotics (Basel). 2024; 13(6).
PMID: 38927235
PMC: 11201024.
DOI: 10.3390/antibiotics13060569.
Shi X, Sharma S, Chmielewski R, Markovic M, VanEpps J, Yau S
Commun Med (Lond). 2024; 4(1):77.
PMID: 38654117
PMC: 11039749.
DOI: 10.1038/s43856-024-00487-x.
Kumar N, Balraj T, Kempegowda S, Prashant A
Antibiotics (Basel). 2024; 13(1).
PMID: 38247605
PMC: 10812490.
DOI: 10.3390/antibiotics13010046.
Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T
Acute Med Surg. 2021; 8(1):e659.
PMID: 34484801
PMC: 8390911.
DOI: 10.1002/ams2.659.
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T
J Intensive Care. 2021; 9(1):53.
PMID: 34433491
PMC: 8384927.
DOI: 10.1186/s40560-021-00555-7.
Antimicrobial Treatment Duration in Sepsis and Serious Infections.
Busch L, Kadri S
J Infect Dis. 2020; 222(Suppl 2):S142-S155.
PMID: 32691838
PMC: 7372214.
DOI: 10.1093/infdis/jiaa247.
"Appropriate" Versus "Inappropriate" Antibiotic Administration, "Prior To" Versus "After" the Diagnosis of Septic Shock. Impact on Patients with Sepsis Admitted to a Saudi Intensive Care Unit.
Algethamy H, Morish A, Numan M, Alotaibi A
Mater Sociomed. 2020; 32(1):20-28.
PMID: 32410887
PMC: 7219728.
DOI: 10.5455/msm.2020.32.20-28.
An approach to antibiotic treatment in patients with sepsis.
Martinez M, Plata-Menchaca E, Ruiz-Rodriguez J, Ferrer R
J Thorac Dis. 2020; 12(3):1007-1021.
PMID: 32274170
PMC: 7139065.
DOI: 10.21037/jtd.2020.01.47.
Driving blind: instituting SEP-1 without high quality outcomes data.
Wang J, Strich J, Applefeld W, Sun J, Cui X, Natanson C
J Thorac Dis. 2020; 12(Suppl 1):S22-S36.
PMID: 32148923
PMC: 7024755.
DOI: 10.21037/jtd.2019.12.100.
Predictive Accuracy of the Quick Sepsis-related Organ Failure Assessment Score in Brazil. A Prospective Multicenter Study.
Machado F, Cavalcanti A, Monteiro M, Sousa J, Bossa A, Bafi A
Am J Respir Crit Care Med. 2020; 201(7):789-798.
PMID: 31910037
PMC: 7124712.
DOI: 10.1164/rccm.201905-0917OC.
Early Infectious Disease Consultation Is Associated With Lower Mortality in Patients With Severe Sepsis or Septic Shock Who Complete the 3-Hour Sepsis Treatment Bundle.
Madaline T, Wadskier Montagne F, Eisenberg R, Mowrey W, Kaur J, Malik M
Open Forum Infect Dis. 2019; 6(10):ofz408.
PMID: 31687417
PMC: 6821928.
DOI: 10.1093/ofid/ofz408.
Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy.
Luo H, Wang N, Huang L, Zhou X, Jin J, Li C
J Immunother Cancer. 2019; 7(1):271.
PMID: 31640816
PMC: 6806557.
DOI: 10.1186/s40425-019-0767-x.
Allergic Immune Diseases and the Risk of Mortality Among Patients Hospitalized for Acute Infection.
Verhoef P, Bhavani S, Carey K, Churpek M
Crit Care Med. 2019; 47(12):1735-1742.
PMID: 31599813
PMC: 6861689.
DOI: 10.1097/CCM.0000000000004020.
Real World Patterns of Antimicrobial Use and Microbiology Investigations in Patients with Sepsis outside the Critical Care Unit: Secondary Analysis of Three Nation-Wide Point Prevalence Studies.
Kopczynska M, Sharif B, Unwin H, Lynch J, Forrester A, Zeicu C
J Clin Med. 2019; 8(9).
PMID: 31470569
PMC: 6780948.
DOI: 10.3390/jcm8091337.
Patient Outcomes and Cost-Effectiveness of a Sepsis Care Quality Improvement Program in a Health System.
Afshar M, Arain E, Ye C, Gilbert E, Xie M, Lee J
Crit Care Med. 2019; 47(10):1371-1379.
PMID: 31306176
PMC: 7195842.
DOI: 10.1097/CCM.0000000000003919.
The Impact of EGDT on Sepsis Mortality in a Single Tertiary Care Center in Lebanon.
El Khuri C, Abou Dagher G, Chami A, Chebl R, Amoun T, Bachir R
Emerg Med Int. 2019; 2019:8747282.
PMID: 30863642
PMC: 6378781.
DOI: 10.1155/2019/8747282.
Antimicrobial exposure and the risk of delirium in critically ill patients.
Grahl J, Stollings J, Rakhit S, Person A, Wang L, Thompson J
Crit Care. 2018; 22(1):337.
PMID: 30541600
PMC: 6291937.
DOI: 10.1186/s13054-018-2262-z.
Delafloxacin Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone.
Pfaller M, Flamm R, McCurdy S, Pillar C, Shortridge D, Jones R
J Clin Microbiol. 2018; 56(8).
PMID: 29848564
PMC: 6062791.
DOI: 10.1128/JCM.00339-18.